ICE Biopharma Can Launch in Europe, Canada and Beyond

---

How Will ICE Biopharma Launch Your Product?

---

Partnering Designed To Enhance Biotech Enterprise Value

---

Key Partnership Deliverables

---

Align to optimize European and Canadian Regulatory and Market Access Data Packages

Partner or ICE Biopharma can hold Marketing Authorizations (EMA, MHRA, Health Canada, SwissMedic)

Early Access Program Evaluation and Execution

Pricing and Reimbursement Preparation, Negotiation and Execution

ICE Biopharma will acquire Product from Partner and Manage Supply & Distribution in the Territory

A Joint Steering Committee will Oversee Commercialization

Expert Distribution Management

Manage Local Regulatory & Healthcare Compliance Landscape